Consort Medical Completes Acquisition of Aesica

Consort Medical plc has completed its previously announced acquisition of  Aesica Pharmaceuticals Limited for £230 million ($373 million). Consort Medical plc is a UK company listed on the London Stock Exchange focused on developing and manufacturing disposable medical devices for drug delivery, including inhaled, nasal and injectables products through its core operating division Bespak.

Aesica is a contract development and manufacturing organization for finished dose and active pharmaceutical ingredients.

Source: Consort Medical


Leave a Reply

Your email address will not be published. Required fields are marked *